EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

The Role of CDCA2 in tumor genesis, prognosis and future treatments

Xinyi Lin, Zijian Zou, Jingqin Zhong, Tong Wang, Wenjie Ma, Tu Hu, Wei Sun, Yu Xu, Alexander M M Eggermont, Yong Chen

European Journal of Cancer · 2024-11 · 211 · 114308

DOI: 10.1016/j.ejca.2024.114308 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Cancer, 2024-11. Verfasst von Xinyi Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Hauptthemen laut MEDLINE: Neoplasms, Cell Cycle Proteins, Biomarkers, Tumor. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Anti Cancer Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsCell Cycle ProteinsBiomarkers, TumorHumansPrognosisNuclear ProteinsMolecular Targeted TherapyCarrier Proteins

Stichwörter der Autor:innen

BiomarkerCancerCancer treatmentCell Division Cycle Associated 2MitosisSignaling pathway

Substanzen

Cell Cycle ProteinsBiomarkers, TumorCDCA2 protein, humanNuclear ProteinsCarrier Proteins

Autor:innen und Institutionen

  • Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • University Medical Center Utrecht & Princess Maxima Center, Utrecht, the Netherlands; Comprehensive Cancer Center München, Technical University München & Ludwig Maximilian University, München, Germany.
  • Department of Musculoskeletal Surgery, Fudan University Shanghai Cancer Center, Shanghai, China. Electronic address: chenyong@fudan.edu.cn.

Förderung

  • National Natural Science Foundation of China
  • Shanghai Anti Cancer Association

Zitieren

APA

Lin, X., Zou, Z., Zhong, J., Wang, T., Ma, W., Hu, T., Sun, W., Xu, Y., Eggermont, A. M. M., & Chen, Y. (2024). The Role of CDCA2 in tumor genesis, prognosis and future treatments. European Journal of Cancer, 211, 114308. https://doi.org/10.1016/j.ejca.2024.114308

Vancouver

Lin X, Zou Z, Zhong J, Wang T, Ma W, Hu T, et al. The Role of CDCA2 in tumor genesis, prognosis and future treatments. European Journal of Cancer. 2024;211:114308. doi:10.1016/j.ejca.2024.114308

BibTeX
@article{Lin2024,
  author = {Lin, Xinyi and Zou, Zijian and Zhong, Jingqin and Wang, Tong and Ma, Wenjie and Hu, Tu and Sun, Wei and Xu, Yu and Eggermont, Alexander M M and Chen, Yong},
  title = {The Role of CDCA2 in tumor genesis, prognosis and future treatments},
  journal = {European Journal of Cancer},
  year = {2024},
  volume = {211},
  pages = {114308},
  doi = {10.1016/j.ejca.2024.114308}
}
Kostenlos starten →